Wells Fargo & Company Astrazeneca PLC Put Options Transaction History

Wells Fargo & Company

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	BUY	$55.72 - $67.12 $1.39 Million - $1.68 Million	25,000 Added 33.33%	100,000 $6.63 Million
Q4 2020 Feb 09, 2021	SELL	$48.52 - $58.02 $727,800 - $870,300	-15,000 Reduced 16.67%	75,000 $568,000
Q3 2020 Nov 05, 2020	BUY	$53.07 - $61.1 $764,208 - $879,840	14,400 Added 19.05%	90,000 $431,000
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $3.26 Million - $4.18 Million	75,600 New	75,600 $93,000

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.